ELI LILLY & CO (1LLY.MI) Stock Fundamental Analysis

Europe • Euronext Milan • BIT:1LLY • US5324571083

889.9 EUR
+2.2 (+0.25%)
Last: Feb 9, 2026, 07:00 PM
Fundamental Rating

6

Overall 1LLY gets a fundamental rating of 6 out of 10. We evaluated 1LLY against 55 industry peers in the Pharmaceuticals industry. 1LLY scores excellent on profitability, but there are some minor concerns on its financial health. 1LLY is valued quite expensive, but it does show an excellent growth. With these ratings, 1LLY could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • 1LLY had positive earnings in the past year.
  • In the past year 1LLY had a positive cash flow from operations.
  • 1LLY had positive earnings in each of the past 5 years.
  • 1LLY had a positive operating cash flow in 4 of the past 5 years.
1LLY.MI Yearly Net Income VS EBIT VS OCF VS FCF1LLY.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B

1.2 Ratios

  • The Return On Assets of 1LLY (16.02%) is better than 92.73% of its industry peers.
  • The Return On Equity of 1LLY (77.38%) is better than 98.18% of its industry peers.
  • 1LLY's Return On Invested Capital of 28.89% is amongst the best of the industry. 1LLY outperforms 96.36% of its industry peers.
Industry RankSector Rank
ROA 16.02%
ROE 77.38%
ROIC 28.89%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1LLY.MI Yearly ROA, ROE, ROIC1LLY.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200 300

1.3 Margins

  • 1LLY's Profit Margin of 30.99% is amongst the best of the industry. 1LLY outperforms 98.18% of its industry peers.
  • In the last couple of years the Profit Margin of 1LLY has grown nicely.
  • 1LLY has a Operating Margin of 44.41%. This is amongst the best in the industry. 1LLY outperforms 98.18% of its industry peers.
  • 1LLY's Operating Margin has improved in the last couple of years.
  • 1LLY has a better Gross Margin (83.03%) than 89.09% of its industry peers.
  • 1LLY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 44.41%
PM (TTM) 30.99%
GM 83.03%
OM growth 3Y16.24%
OM growth 5Y10.3%
PM growth 3Y13.11%
PM growth 5Y4.64%
GM growth 3Y2.65%
GM growth 5Y1.35%
1LLY.MI Yearly Profit, Operating, Gross Margins1LLY.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1LLY is creating value.
  • 1LLY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
1LLY.MI Yearly Shares Outstanding1LLY.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
1LLY.MI Yearly Total Debt VS Total Assets1LLY.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • 1LLY has an Altman-Z score of 8.36. This indicates that 1LLY is financially healthy and has little risk of bankruptcy at the moment.
  • 1LLY has a Altman-Z score of 8.36. This is amongst the best in the industry. 1LLY outperforms 92.73% of its industry peers.
  • The Debt to FCF ratio of 1LLY is 6.60, which is on the high side as it means it would take 1LLY, 6.60 years of fcf income to pay off all of its debts.
  • 1LLY has a Debt to FCF ratio of 6.60. This is comparable to the rest of the industry: 1LLY outperforms 43.64% of its industry peers.
  • A Debt/Equity ratio of 1.72 is on the high side and indicates that 1LLY has dependencies on debt financing.
  • The Debt to Equity ratio of 1LLY (1.72) is worse than 78.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.72
Debt/FCF 6.6
Altman-Z 8.36
ROIC/WACC3.09
WACC9.34%
1LLY.MI Yearly LT Debt VS Equity VS FCF1LLY.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

2.3 Liquidity

  • 1LLY has a Current Ratio of 1.55. This is a normal value and indicates that 1LLY is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of 1LLY (1.55) is better than 65.45% of its industry peers.
  • A Quick Ratio of 1.24 indicates that 1LLY should not have too much problems paying its short term obligations.
  • The Quick ratio of 1LLY (1.24) is better than 74.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.24
1LLY.MI Yearly Current Assets VS Current Liabilites1LLY.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

8

3. Growth

3.1 Past

  • 1LLY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 86.23%, which is quite impressive.
  • Measured over the past years, 1LLY shows a very strong growth in Earnings Per Share. The EPS has been growing by 25.01% on average per year.
  • The Revenue has grown by 44.70% in the past year. This is a very strong growth!
  • Measured over the past years, 1LLY shows a very strong growth in Revenue. The Revenue has been growing by 21.58% on average per year.
EPS 1Y (TTM)86.23%
EPS 3Y44.11%
EPS 5Y25.01%
EPS Q2Q%41.73%
Revenue 1Y (TTM)44.7%
Revenue growth 3Y31.69%
Revenue growth 5Y21.58%
Sales Q2Q%42.56%

3.2 Future

  • 1LLY is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.21% yearly.
  • 1LLY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.06% yearly.
EPS Next Y38.64%
EPS Next 2Y31.04%
EPS Next 3Y23.44%
EPS Next 5Y19.21%
Revenue Next Year21.61%
Revenue Next 2Y19.16%
Revenue Next 3Y15.36%
Revenue Next 5Y13.06%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
1LLY.MI Yearly Revenue VS Estimates1LLY.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50B 100B
1LLY.MI Yearly EPS VS Estimates1LLY.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20 40 60

2

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 43.69 indicates a quite expensive valuation of 1LLY.
  • Based on the Price/Earnings ratio, 1LLY is valued a bit more expensive than the industry average as 67.27% of the companies are valued more cheaply.
  • 1LLY is valuated expensively when we compare the Price/Earnings ratio to 28.06, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 31.51 indicates a quite expensive valuation of 1LLY.
  • Based on the Price/Forward Earnings ratio, 1LLY is valued a bit more expensive than 69.09% of the companies in the same industry.
  • 1LLY is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 27.86, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 43.69
Fwd PE 31.51
1LLY.MI Price Earnings VS Forward Price Earnings1LLY.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 1LLY is valued a bit more expensive than the industry average as 69.09% of the companies are valued more cheaply.
  • 1LLY's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. 1LLY is more expensive than 65.45% of the companies in the same industry.
Industry RankSector Rank
P/FCF 155.36
EV/EBITDA 36.5
1LLY.MI Per share data1LLY.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • 1LLY's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of 1LLY may justify a higher PE ratio.
  • A more expensive valuation may be justified as 1LLY's earnings are expected to grow with 23.44% in the coming years.
PEG (NY)1.13
PEG (5Y)1.75
EPS Next 2Y31.04%
EPS Next 3Y23.44%

4

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.68%, 1LLY is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 1.94, 1LLY has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.80, 1LLY's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.68%

5.2 History

  • On average, the dividend of 1LLY grows each year by 15.59%, which is quite nice.
Dividend Growth(5Y)15.59%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 1LLY pays out 28.28% of its income as dividend. This is a sustainable payout ratio.
  • 1LLY's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP28.28%
EPS Next 2Y31.04%
EPS Next 3Y23.44%
1LLY.MI Yearly Income VS Free CF VS Dividend1LLY.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B 20B
1LLY.MI Dividend Payout.1LLY.MI Dividend Payout, showing the Payout Ratio.1LLY.MI Dividend Payout.PayoutRetained Earnings

ELI LILLY & CO

BIT:1LLY (2/9/2026, 7:00:00 PM)

889.9

+2.2 (+0.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-04
Earnings (Next)04-30
Inst Owners83.09%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap841.29B
Revenue(TTM)65.18B
Net Income(TTM)18.41B
Analysts81.08
Price Target992.48 (11.53%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.68%
Yearly Dividend4.18
Dividend Growth(5Y)15.59%
DP28.28%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.28%
Min EPS beat(2)14.51%
Max EPS beat(2)22.05%
EPS beat(4)4
Avg EPS beat(4)13.1%
Min EPS beat(4)6.45%
Max EPS beat(4)22.05%
EPS beat(8)7
Avg EPS beat(8)12.06%
EPS beat(12)10
Avg EPS beat(12)23.73%
EPS beat(16)13
Avg EPS beat(16)17.41%
Revenue beat(2)2
Avg Revenue beat(2)6.77%
Min Revenue beat(2)4.72%
Max Revenue beat(2)8.81%
Revenue beat(4)2
Avg Revenue beat(4)2.95%
Min Revenue beat(4)-1.24%
Max Revenue beat(4)8.81%
Revenue beat(8)4
Avg Revenue beat(8)2.39%
Revenue beat(12)7
Avg Revenue beat(12)2.64%
Revenue beat(16)9
Avg Revenue beat(16)2.04%
PT rev (1m)7.22%
PT rev (3m)24.94%
EPS NQ rev (1m)-5.7%
EPS NQ rev (3m)-4.57%
EPS NY rev (1m)2.31%
EPS NY rev (3m)7.96%
Revenue NQ rev (1m)0.97%
Revenue NQ rev (3m)1.78%
Revenue NY rev (1m)1.28%
Revenue NY rev (3m)4.59%
Valuation
Industry RankSector Rank
PE 43.69
Fwd PE 31.51
P/S 16.83
P/FCF 155.36
P/OCF 62.26
P/B 42.03
P/tB 87.34
EV/EBITDA 36.5
EPS(TTM)20.37
EY2.29%
EPS(NY)28.24
Fwd EY3.17%
FCF(TTM)5.73
FCFY0.64%
OCF(TTM)14.29
OCFY1.61%
SpS52.88
BVpS21.17
TBVpS10.19
PEG (NY)1.13
PEG (5Y)1.75
Graham Number98.51
Profitability
Industry RankSector Rank
ROA 16.02%
ROE 77.38%
ROCE 35.28%
ROIC 28.89%
ROICexc 33.3%
ROICexgc 41.12%
OM 44.41%
PM (TTM) 30.99%
GM 83.03%
FCFM 10.83%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y16.24%
OM growth 5Y10.3%
PM growth 3Y13.11%
PM growth 5Y4.64%
GM growth 3Y2.65%
GM growth 5Y1.35%
F-Score7
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 1.72
Debt/FCF 6.6
Debt/EBITDA 1.44
Cap/Depr 507.66%
Cap/Sales 16.2%
Interest Coverage 250
Cash Conversion 56.78%
Profit Quality 34.96%
Current Ratio 1.55
Quick Ratio 1.24
Altman-Z 8.36
F-Score7
WACC9.34%
ROIC/WACC3.09
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)86.23%
EPS 3Y44.11%
EPS 5Y25.01%
EPS Q2Q%41.73%
EPS Next Y38.64%
EPS Next 2Y31.04%
EPS Next 3Y23.44%
EPS Next 5Y19.21%
Revenue 1Y (TTM)44.7%
Revenue growth 3Y31.69%
Revenue growth 5Y21.58%
Sales Q2Q%42.56%
Revenue Next Year21.61%
Revenue Next 2Y19.16%
Revenue Next 3Y15.36%
Revenue Next 5Y13.06%
EBIT growth 1Y82.81%
EBIT growth 3Y53.07%
EBIT growth 5Y34.09%
EBIT Next Year43.42%
EBIT Next 3Y24.82%
EBIT Next 5Y19.97%
FCF growth 1Y382.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y166.27%
OCF growth 3YN/A
OCF growth 5YN/A

ELI LILLY & CO / 1LLY.MI FAQ

What is the fundamental rating for 1LLY stock?

ChartMill assigns a fundamental rating of 6 / 10 to 1LLY.MI.


What is the valuation status of ELI LILLY & CO (1LLY.MI) stock?

ChartMill assigns a valuation rating of 2 / 10 to ELI LILLY & CO (1LLY.MI). This can be considered as Overvalued.


Can you provide the profitability details for ELI LILLY & CO?

ELI LILLY & CO (1LLY.MI) has a profitability rating of 8 / 10.


What is the expected EPS growth for ELI LILLY & CO (1LLY.MI) stock?

The Earnings per Share (EPS) of ELI LILLY & CO (1LLY.MI) is expected to grow by 38.64% in the next year.


Is the dividend of ELI LILLY & CO sustainable?

The dividend rating of ELI LILLY & CO (1LLY.MI) is 4 / 10 and the dividend payout ratio is 28.28%.